| 000 | 02985cam a2200325 4500500 | ||
|---|---|---|---|
| 005 | 20250121154613.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_ada Silva, Neuza _eauthor |
| 700 | 1 | 0 |
_a Augustin, Matthias _eauthor |
| 700 | 1 | 0 |
_a Langenbruch, Anna _eauthor |
| 700 | 1 | 0 |
_a Mrowietz, Ulrich _eauthor |
| 700 | 1 | 0 |
_a Reich, Kristian _eauthor |
| 700 | 1 | 0 |
_a Thaçi, Diamant _eauthor |
| 700 | 1 | 0 |
_a Boehncke, Wolf-Henning _eauthor |
| 700 | 1 | 0 |
_a Kirsten, Natalia _eauthor |
| 700 | 1 | 0 |
_a Danckworth, Alexandra _eauthor |
| 700 | 1 | 0 |
_a Sommer, Rachel _eauthor |
| 245 | 0 | 0 | _aDisease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care |
| 260 | _c2020. | ||
| 500 | _a23 | ||
| 520 | _aBackground: Psoriasis may cause considerable disease burden. The involvement of sexually-sensitive/visible body areas has been associated with decreased quality of life (QoL), more depressive symptoms and stigmatisation experiences. Objectives: To characterise the topical distribution of psoriasis in sexually-sensitive and visible areas, to examine its impact on QoL and to determine which specific patient needs should be addressed in routine care. Materials and Methods: Patients with psoriasis vulgaris were recruited within a cross-sectional nationwide survey, involving 157 randomly assigned German dermatology practices/clinics. The main outcome measures were the EuroQoL visual analogue scale (EQ VAS), the Dermatology Life Quality Index (DLQI), the Patient Needs Questionnaire (PNQ) and a grid scheme for topical distribution of psoriasis. Results: The sample included 2,009 patients (43.7% female; 21.8% ≥ 65 years; 64.2% with lesions in sexually-sensitive areas and 86.2% with lesions in visible areas). Patients with concomitant involvement of sexually-sensitive and visible areas presented increased DLQI impairments relative to patients with no involvement of sexually-sensitive or visible areas (F(3,1723) = 4.091, p = 0.007). Significant differences were also found for patient needs dimensions (PNQ) depending on the body areas affected (F(15, 4602) = 2.936, p < 0.001). Significant effects of gender and age group were also observed. Increased disease severity, lesions in both sexually-sensitive/visible or only visible areas, and increased QoL impairment were associated with specific patient needs. Conclusion: These results highlight the need for proactive evaluation of difficult-to-communicate impairments and the requirements for patient-centred routine care. | ||
| 690 | _apsoriasis | ||
| 690 | _asexually-sensitive body areas | ||
| 690 | _aquality of life | ||
| 690 | _avisible body areas | ||
| 690 | _apatient needs | ||
| 786 | 0 | _nEuropean Journal of Dermatology | 30 | 3 | 2020-05-01 | p. 267-278 | 1167-1122 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/revue-european-journal-of-dermatology-2020-3-page-267?lang=en&redirect-ssocas=7080 |
| 999 |
_c602746 _d602746 |
||